Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Lung Diseases(Electronic Edition) ›› 2025, Vol. 18 ›› Issue (02): 295-299. doi: 10.3877/cma.j.issn.1674-6902.2025.02.017

• Original articles • Previous Articles    

Clinical application of multimode respiratory training device combined with comprehensive pulmonary rehabilitation training during the perioperative period of thoracoscopic surgery for lung cancer

Dongxia Cao1, Enyan Yang2,(), Qimei Fu3, Xinyi Xu3, Ronghua Wang4, Jingwen Zhang5   

  1. 1. Department of Cardiothoracic Urology,Air Force Hospital of Eastern Theater Command,Nanjing 210001,China
    2. Department of Critical Care Medicine,Air Force Hospital of Eastern Theater Command,Nanjing 210001,China
    3. Department of Nursing,Air Force Hospital of Eastern Theater Command,Nanjing 210001,China
    4. Department of Respiratory Medicine,Air Force Hospital of Eastern Theater Command,Nanjing 210001,China
    5. Department of General Surgery,Second Medical Center,PLA General Hospital,Beijing 100039,China
  • Received:2024-11-07 Online:2025-04-25 Published:2025-05-26
  • Contact: Enyan Yang

Abstract:

Objective

To analyze the application effect of a multimodal respiratory training device combined with comprehensive pulmonary rehabilitation training (PRT) management during the perioperative period of thoracoscopic surgery for lung cancer.

Methods

Seventy-two patients undergoing thoracoscopic lobectomy for lung cancer in our hospital from February 2023 to October 2023 were selected and randomly divided into a control group (37 cases) and an observation group (35 cases). The control group received conventional interventions perioperative care for lung cancer,while the observation group received comprehensive PRT management and a multimodal respiratory training device in addition to the conventional interventions. Lung function indicators (FEV1,FVC,PEF,SpO2),quality of life scores (QLICP-LU,GSES),and postoperative complications were compared between the two groups at preoperative day 1,postoperative day 5,and postoperative one month to evaluate the intervention efficacy.

Results

On preoperative day 1,the observation group showed higher FEV1(57.83±3.85%),FVC (2.26±0.35)L,PEF(4.20±0.27)L/m,and SpO2(93.34±3.06%) compared to the control group (P<0.05). By postoperative day 28,the observation group demonstrated significantly higher FEV1(69.54±7.13)%,FVC(2.83±0.48)L,PEF(4.48±0.39)L/m,and SpO2(95.49±3.08)% than the control group (P<0.01). On postoperative day 5,the observation group had higher QLICP-LU scores (160.40±14.04) and GSES scores (34.34±2.88) compared to the control group (149.22±20.84),(31.91±4.81)(P<0.05). By postoperative day 28,the observation group maintained higher QLICP-LU (178.80±13.17) and GSES scores (35.80±3.62) than the control group(158.05±16.71),(32.32±4.74)(P<0.05). The total incidence of postoperative pulmonary complications in the observation group (31.43%) was lower than that in the control group (78.38%)(P<0.05). Additionally,fewer patients in the observation group required postoperative sputum suction 7 cases (20.00%) compared to the control group 16 cases (43.24%)(P <0.05). There were no deaths one month after the operation.

Conclusion

The combination of a multimodal respiratory training device and comprehensive PRT management improves perioperative lung function,reduces the incidence of pulmonary complications,and enhances quality of life in lung cancer patients undergoing thoracoscopic surgery. This approach is an effective perioperative management strategy with significant clinical implications.

Key words: Bronchogenic carcinoma, Pulmonary rehabilitation training, Multimode respiratory training device, Perioperative period of thoracoscopic surgery

京ICP 备07035254号-28
Copyright © Chinese Journal of Lung Diseases(Electronic Edition), All Rights Reserved.
Tel: 023-65425691 E-mail: xqcjld@163.com
Powered by Beijing Magtech Co. Ltd